Search Results:

searched for: emtricitabine/rilpivirine/tenofovir

emtricitabine/rilpivirine/tenofovir

Drug Name	Form	Strength	Formulary	Non-Formulary	Specialty	Restricted
Odefsey	TABLET, ORAL	200 mg-25 mg-25 mg

Last updated: Oct. 19, 2020

Black Box Warning: Lactic acidosis, severe hepatomegaly; hepB co-infection

Facts and Comparisons (Monographs)
FDA DailyMed Package Insert
UpToDate

This site is intended for the staff of Prisma Health-Midlands.
While others may view accessible pages, Prisma Health-Midlands makes no warranted, expressed or implied,
use of this information outside of Prisma Health-Midlands.